Le Lézard
Classified in: Science and technology, Business
Subject: CXP

Growth performance sparks investor confidence in Aevi's in-person payment orchestration platform


LONDON, Jan. 30, 2024 /PRNewswire/ -- Aevi, the industry-leading platform provider for in-person payment orchestration, proudly achieved a transformative phase of growth in 2023 as it demonstrated resilience and success, marked by an impressive +25% growth in recurring revenues during a period of industry average suppressed growth rates.

 

HPE Growth providing additional investment capital to further accelerate Aevi's sustainable growth momentum

 

Following Aevi's separation from Diebold Nixdorf last September, led by HPE Growth, an established pan-European growth equity firm, Aevi showed compelling developments in growth, efficiency, and profitability, underscoring its strategic trajectory as a fully independent company. This acceleration further cemented the trust and conviction of its current shareholders and resulted in HPE Growth providing additional investment capital to further accelerate the company's sustainable growth momentum to further scale, solidify its competitive advantage, and enhance the product platform used by market-leading clients.

Frederic Huynen, Partner at HPE Growth, commented, "We recognize Aevi as the frontrunner in the market of in-person payment orchestration to enable the most reliable, secure but flexible omnichannel payment experience. Aevi's embedded platform, distinguished by its openness and API-driven architecture, offers a unique value proposition to among others PSP and ISV customers to integrate POS payments and data across all channels, to maximize the payment experience for the merchants and their end-clients."

"Having operated independently and owned by a growth-equity shareholder has already proven to benefit our agility, stakeholder alignment, and independent strategic evolution. Being well-funded, Aevi eagerly anticipates a thriving 2024 together with its supportive and trusting shareholders. Finally, Aevi can focus on what is central in its culture - the customer," stated Mike Camerling, CEO at Aevi. "The injection of additional financing from HPE Growth is a testament to our shared vision and confidence in Aevi's capabilities. This strategic move underscores our commitment to pushing the boundaries of in-person payment orchestration."

As Aevi embarks on this next dynamic chapter, the company remains focused on its commitment to shaping the future of card-present payments with its orchestration solutions connecting the world of POS with eCommerce in Europe and the US and invites stakeholders, partners, and clients to join them on this exciting journey.

About Aevi
Aevi leads in-person payment orchestration with innovative, industry-redefining solutions. Their global, open platform is API-driven, device-agnostic, and solution-independent, enabling seamless payments and data flow across all channels.

Aevi's journey beginning in 2012 as part of Diebold Nixdorf, saw significant milestones, including investments from HPE (2016) and Mastercard (2021). In 2023, HPE Growth acquired Diebold Nixdorf's stake, propelling Aevi into a new phase of entrepreneurial expansion.

Logo - https://mma.prnewswire.com/media/2327856/Aevi_Logo.jpg
Photo - https://mma.prnewswire.com/media/2327810/aevi.jpg

Contact: Sarah Koch, [email protected], +49 5251 6941554

 

Aevi Logo

 


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: